XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.3
Stock Compensation (Tables)
9 Months Ended
Sep. 30, 2023
Stock Compensation  
Schedule of share-based compensation expense recognized

The estimated grant date fair value of the Company’s share-based awards is amortized on a straight-line basis over the awards’ service periods. Share based compensation expense recognized was as follows (in thousands):

Nine Months Ended September 30, 

    

2023

2022

    

Research and development

$

444

$

672

Selling, general and administrative

 

1,753

 

2,257

Cost of goods sold

(2)

Total stock-based compensation

$

2,197

$

2,927

Summary of stock option activity

Options Outstanding

    

    

    

Weighted 

Average 

Weighted 

Remaining 

Average 

Contractual 

Number of 

Exercise 

Term 

Shares

Price

(in years)

Balance, December 31, 2022

 

351,709

$

49.15

6.94

Granted

 

130,150

1.01

Forfeited/Cancelled

 

(51,060)

47.51

Balance, September 30, 2023

 

430,799

$

34.80

7.12

Vested or expected to vest at September 30, 2023

 

430,799

$

34.80

7.12

Exercisable at September 30, 2023

 

263,962

$

48.18

5.87

Schedule of weighted-average assumptions:

September 30, 

    

2023

    

2022

    

    

Expected term of options (in years)

 

5.7

 

5.7

 

 

Risk-free interest rate

 

3.9

%  

2.7

%  

 

Expected volatility

 

110.3

%  

98.0

%  

 

Dividend yield

 

%  

%  

 

Schedule of changes in the status of non-vested RSU

    

    

Weighted 

Average 

Number of 

Grant Date

Awards

Fair Value

Non-vested at December 31, 2022

 

366,777

$

10.43

Granted

 

500,000

1.78

Vested

 

(3,025)

24.55

Forfeited/Cancelled

 

(82,792)

5.73

Non-vested at September 30, 2023

 

780,960

$

7.90

Schedule of shares available to be granted under equity incentive plans

At September 30, 2023, the Company has the following shares available to be granted under its equity incentive plans:

    

    

Inducement 

2023 Plan

Plan

Available at December 31, 2022

 

404,807

 

12,000

Authorized

 

1,287,958

Granted

 

(630,150)

Shares withheld for taxes not issued

794

Forfeited/Cancelled

 

133,852

Available at September 30, 2023

 

1,197,261

 

12,000

Schedule of shares of common stock reserved/available

At September 30, 2023, the Company has reserved the following shares of common stock for issuance:

Stock options outstanding under 2013 Plan

    

306,349

Stock options outstanding under 2023 Plan

116,450

Restricted stock units outstanding under 2013 Plan

780,960

Stock options outstanding under Inducement Plan

 

8,000

Warrants outstanding

 

3,145,394

Total shares of common stock reserved for future issuance

 

4,357,153